GW Link

Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Eliminating Hepatitis C by Improving Access to Hepatitis C Care and Treatment

Grants to New York Nonprofits to Provide Access
to Treatment for People with Hepatitis C

Agency Type:

State

Funding Source:

Add to My Calendar 

New York State Department of Health AIDS Institute (NYSDOH AI) - Division of HIV and Hepatitis Health Care - Bureau of Hepatitis Health Care, and Health Research, Inc. (HRI)

Deadline Date:

10/29/19

Description:

Request a Grant Writer

Grants to New York nonprofit health care organizations to increase access to treatment for people suffering from hepatitis C (HCV). Funding is intended for programs that provide access to treatment and care for people with HCV, increase the rate of successful HCV initiation and treatment, and increase the number of people who are cured of HCV. Special consideration will be given to populations that are underserved and socially disadvantaged.

The New York State Department of Health AIDS Institute (NYSDOH AI) Division of HIV and Hepatitis Health Care, Bureau of Hepatitis Health Care, and Health Research, Inc. (HRI) announce the availability funding in New York State (NYS) and federal funding for five (5) years to increase the number of people who are treated and cured for hepatitis C (HCV). As part of New York State’s (NYS’s) plan to eliminate HCV, this will be accomplished by creating a primary care-based integrated multidisciplinary model of care to serve all populations in an equitable manner, especially those currently underserved and socially disadvantaged. Funded applicants will conduct targeted outreach, linkage and care coordination to assist people with HCV, and HIV/HCV in accessing timely HCV medical care and appropriate supportive services in a primary care setting.

To impact the HCV epidemic and move towards elimination, models of care are needed to optimize the HCV care continuum by: outreaching to people who are most at risk and identifying those with HCV; proactively addressing the social and structural barriers that prevent them from engaging in care and prevention; facilitating health systems navigation and patient support; and creating convenient, accessible, multidisciplinary methods of HCV care and treatment delivery.

The goals of this RFA are to: 

  • Increase the number of people living with HCV who are linked to care; 
  • Increase HCV treatment initiation and completion rates; and
  • Increase the number of people cured of HCV.

This will be accomplished by conducting targeted client outreach and recruitment and by providing care coordination, peer-delivered services, and HCV care and treatment utilizing a multidisciplinary care team approach in a primary care setting. Programs are expected to serve all people with HCV in an equitable manner, with attention to ensuring non-discriminatory care to those currently underserved and socially disadvantaged. The priority populations for this RFA are people with mono-infection of HCV and/or co-infection of HIV/HCV. This includes uninsured persons.

Successful applicants will demonstrate their ability to:

  • Outreach, recruit, and link people living with HCV to care and services;
  • Provide care coordination to assess and address issues impacting care;
  • Provide comprehensive, high-quality HCV medical care, treatment, and peer-delivered supportive services to all people with HCV;
  • Provide services that are culturally responsive, trauma-informed, and free of stigma and discrimination
  • Design a program that addresses the social determinants of health that impact access to HCV care and completion of treatment (see Plan to Address Social Determinants of Health - Attachment 2);
  • Prescribe MAT (Medication for Addiction Treatment); and
  • Involve people with lived experience of HCV in the planning and design of the proposed program.

For information on program requirements, see page 9 of the RFP attached below.


GrantWatch ID#:

GrantWatch ID#: 187075

Estimated Total Program Funding:

$4,500,000

Number of Grants:

Up to 15 awards

Estimated Size of Grant:

Annual awards will not exceed $300,000.

Term of Contract:

Funding will be awarded over a period of five years. It is expected that NYS contracts resulting from this RFA will have the following multi-year time period: July 1, 2020 – June 30, 2025.

HRI-funded contracts resulting from this RFA will be for 12-month terms. The anticipated start date of HRI contracts is July 1, 2020. However, depending on the funding source, the initial contract term could be for a shorter time period. HRI awards may be renewed for up to four (4) additional annual contract periods based on satisfactory performance and availability of funds.

Additional Eligibility Criteria:

- Applicant must be prequalified in the New York State Grants Gateway, if not exempt, on the date applications are due;
- Applicant must be a not-for-profit health care organization licensed by the NYSDOH under Article 28 of the NYS Public Health Law; and
- Applicant has submitted Attachment 1 - Statement of Assurances signed by the Chief
Executive Officer (CEO) or Designee to certify the organization meets all criteria listed on Attachment 1. Attachment 1 should be submitted via the Grants Gateway in the PreSubmission Uploads section of the online application.

Preference will be given to applicants that demonstrate the following:
- A minimum of five (5) years of experience delivering HCV medical care, treatment, and supportive services within a primary care setting;
- Has at least one provider qualified under the Drug Addiction Treatment Act of 2000 (DATA 2000) to prescribe medication for addiction treatment (MAT) onsite, such as buprenorphine/suboxone or methadone; and
- Has at least one peer certified through the NYSDOH AI Peer Certification Program in the HCV and/or harm reduction tracks.

Pre-Application Information:

Key Dates:
- RFA Release Date: September 12, 2019
- Questions Due: September 26, 2019 by 4:00 PM ET
- Questions, Answers and Updates Posted: (on or about) October 10, 2019
- Applications Due: October 29, 2019 by 4:00 PM ET

In order to apply for this RFA, eligible applicants must be prequalified in the New York State Grants Gateway and must submit an application via the New York State Grants Gateway.

Once the application is complete, prospective grantees are strongly to submit their applications at least 48 hours prior to the due date and time.

All substantive questions must be submitted to Colleen Flanigan. To the degree possible, each inquiry should cite the RFA section and paragraph to which it refers.

Applicants may submit up to two (2) applications in response to this RFA. If applying for more than one region, a separate application must be submitted for each region.

View this opportunity in NYS Grants Gateway: https://grantsgateway.ny.gov/IntelliGrants_NYSGG/module/nysgg/goportal.aspx?NavItem1=3

Contact Information:

Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.

To apply: https://grantsgateway.ny.gov/IntelliGrants_NYSGG/login2.aspx

Colleen Flanigan, Director Bureau of Hepatitis Health Care
New York State Department of Health/AIDS Institute
hepatabc@health.ny.gov

Funding or Pin Number:

18344

URL for Full Text (RFP):

Geographic Focus:

USA: New York City;   New York